What Happens to LH Levels When You Have PCOS?

What Happens to LH Levels When You Have PCOS?

In PCOS, LH is almost always elevated relative to FSH, and the ratio flips from its normal 1:1 balance toward 2:1, 3:1, or beyond. This drives the ovaries to overproduce androgens and prevents follicles from maturing into a released egg. The main caveat: LH elevation is most pronounced in lean women with PCOS; in women with significant insulin resistance and higher body weight, insulin itself can suppress SHBG and worsen androgen excess even when LH appears only modestly elevated.

---

Why LH Is Almost Always High in PCOS

Luteinizing hormone is released in pulses from the pituitary gland. In a normal menstrual cycle, those pulses are slow and steady during the follicular phase, then surge briefly at ovulation, and then quiet down in the luteal phase. In PCOS, the pulse frequency is accelerated — the hypothalamus fires GnRH (gonadotropin-releasing hormone) faster than normal, which preferentially drives LH secretion over FSH secretion (Balen et al., Human Reproduction 1995; PMID: 8567796).

FSH is what matures a follicle. LH, in excess, stimulates the theca cells of the ovary to produce androgens — testosterone and androstenedione — rather than allowing the follicle to complete its development and release an egg. The result is a cascade:

1. Elevated LH → excess androgen production in theca cells
2. Excess androgens → impaired follicle maturation
3. Impaired maturation → the follicle stalls and becomes a cyst
4. No ovulation → no progesterone production in the luteal phase
5. Estrogen without progesterone feedback → pituitary keeps firing LH

This self-reinforcing loop is why PCOS is so persistent once it gets established. The hypothalamic-pituitary-ovarian axis loses its normal cyclical rhythm and settles into a state of chronic LH excess.

Research confirms this pattern clearly. A landmark study found that women with PCOS had significantly higher mean LH concentrations and LH pulse frequency compared to healthy controls matched for age and BMI (Taylor et al., Journal of Clinical Endocrinology & Metabolism 1997; PMID: 9284708). Another study demonstrated that the LH:FSH ratio above 2 was present in roughly 60% of PCOS cases when measured on a random clinic day — but that number climbed substantially when serial blood draws were used, suggesting single-point testing misses many elevated readings (Regan et al., Human Reproduction 1990; PMID: 2205744).

---

The LH:FSH Ratio and What It Actually Tells You

A normal LH:FSH ratio is approximately 1:1 in the early follicular phase. In PCOS, clinical guidelines have historically used a ratio of ≥2:1 (and sometimes ≥3:1) as a diagnostic indicator, though the 2003 Rotterdam criteria moved away from requiring the ratio for diagnosis. Despite this, the ratio remains clinically meaningful: a higher ratio correlates with more severe ovulatory dysfunction, a lower antral follicle response to FSH stimulation during fertility treatment, and greater androgen excess.

Importantly, LH levels and the ratio fluctuate significantly:

• Time of day: LH is higher in the morning
• Day of cycle: If the woman has any cycle at all, LH differs across phases
• Body weight: Adipose tissue converts androgens to estrogen (aromatization), and higher estrogen can partially suppress LH pulses
• Stress: Acute stress transiently suppresses LH; chronic HPA axis activation via elevated cortisol can also blunt pulsatility

This variability is why a single lab draw can be misleading. If your LH came back normal but your symptoms point to PCOS, it is worth discussing repeat testing at the same time of day in the early follicular phase (days 2–5 of the cycle, or randomly if cycles are absent).

You can read more about how related hormones shift in PCOS in these deep-dives: what happens to testosterone in PCOS and what happens to DHEA-S levels in PCOS, since androgen excess is directly downstream of LH dysregulation.

---

How Insulin Resistance Amplifies the LH Problem

For many women with PCOS, insulin resistance is the fuel that keeps LH dysregulation burning. Here is the mechanism:

• High circulating insulin directly stimulates ovarian theca cells to produce more androgens, acting synergistically with LH
• High insulin suppresses sex hormone-binding globulin (SHBG) in the liver, which means more free testosterone is biologically active even if total testosterone looks borderline
• Elevated androgens feed back to the hypothalamus and speed up GnRH pulse frequency, which drives more LH

Studies using insulin-sensitizing agents like metformin have shown reductions in LH pulse frequency alongside improvements in the LH:FSH ratio, supporting the idea that insulin resistance is not just a downstream consequence of PCOS but an active driver of LH excess (Lord et al., Cochrane Database of Systematic Reviews 2003; PMID: 12535498).

This is also why HbA1c and insulin resistance matter so much in the PCOS picture — addressing glucose metabolism is often the most leveraged intervention for restoring hormonal balance, including LH.

---

Stress, Cortisol, and LH: A Complex Relationship

Chronic stress is one of the factors most commonly reported by women with PCOS as a trigger for symptom flares — irregular periods, worsening acne, increased hair loss. There is a real biological reason for this. The HPA (hypothalamic-pituitary-adrenal) axis and the HPO (hypothalamic-pituitary-ovarian) axis share regulatory infrastructure at the hypothalamic level.

Cortisol and CRH (corticotropin-releasing hormone) can suppress GnRH pulsatility in the short term. Paradoxically, in the context of chronic low-grade stress that characterizes many women with PCOS, adrenal androgen production increases (DHEA-S rises), which feeds the androgen excess and indirectly sustains LH dysregulation. PCOS itself is associated with dysregulated cortisol metabolism — women with PCOS have been shown to have altered cortisol clearance and higher adrenal androgen output compared to controls (Rodin et al., Clinical Endocrinology 1994; PMID: 7955434).

Practical stress management therefore is not just psychological self-care — it has a direct hormonal rationale. Techniques with evidence behind them include:

• Mindfulness-based stress reduction (MBSR): Shown to lower cortisol AUC and reduce perceived stress in women with hormonal dysfunction
• Consistent sleep timing: Sleep irregularity disrupts GnRH pulsatility independently of stress
• Moderate aerobic exercise: Lowers fasting insulin and has been shown to reduce LH:FSH ratio in PCOS over 12–16 weeks
• Adaptogenic herbs: Ashwagandha (KSM-66) at 600 mg/day has demonstrated significant reductions in serum cortisol compared to placebo in double-blind trials (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798)

---

Weight, Body Composition, and LH in PCOS

Body weight significantly modifies how LH behaves in PCOS. Lean women with PCOS tend to have the most dramatically elevated LH levels and the clearest LH:FSH ratio inversion. In women with higher BMI and more pronounced insulin resistance, LH may appear only modestly elevated because adipose-derived estrogen partially suppresses pituitary LH output — but the underlying dysfunction has simply shifted downstream toward insulin-mediated androgen excess.

This creates a clinical trap: a woman with higher body weight and PCOS may receive a "normal" LH result and feel dismissed, even though her condition is actively driven by insulin resistance and adrenal androgen excess. If you recognize this pattern, reading about SHBG levels in PCOS is worth your time — SHBG is the most sensitive marker of insulin-driven androgen excess and often tells the story that LH misses.

From a body composition standpoint, weight gain around the middle in PCOS is not simply a calorie problem. Visceral fat is metabolically active and worsens insulin resistance, which in turn sustains the androgen excess that began with LH dysregulation. Interventions that improve insulin sensitivity — a lower-glycemic diet, resistance training, adequate sleep — tend to improve LH pulsatility as a secondary effect.

---

Can a Tumor Cause Elevated LH in PCOS-Like Presentations?

This is less common but clinically important. Rarely, an LH-secreting pituitary adenoma or an ovarian or adrenal tumor can produce a hormonal picture that mimics or overlaps with PCOS — elevated androgens, irregular cycles, and sometimes elevated LH. Ovarian tumors (such as a granulosa cell tumor or a Sertoli-Leydig cell tumor) and adrenal tumors can cause androgen excess independent of pituitary LH but may present similarly.

Red flags that suggest a workup beyond routine PCOS investigation include:

• Rapid onset of androgenic symptoms (weeks to months rather than gradual)
• Total testosterone above 150–200 ng/dL on a single measurement
• DHEA-S dramatically elevated (above 700–800 µg/dL)
• LH persistently high despite no menstrual activity and no response to lifestyle interventions
• MRI findings or pelvic ultrasound showing a mass

If any of these apply to your situation, this warrants prompt evaluation by an endocrinologist or reproductive endocrinologist — not just a functional medicine approach. A diagnosis of PCOS is one of exclusion, which means structural and tumorous causes must be ruled out first.

---

What This Means for Your Formula

Ones builds personalized supplement formulas from lab results, wearable data, and health history — and LH dysregulation in PCOS touches several systems that targeted supplementation can meaningfully support.

Ashwagandha (KSM-66, 600 mg): This is one of the most studied adaptogens for HPA axis regulation. In the Chandrasekhar 2012 trial (PMID: 23439798), participants taking 300 mg of KSM-66 twice daily for 60 days showed a 27.9% reduction in serum cortisol versus 7.9% in the placebo group. Since cortisol dysregulation intersects with GnRH pulsatility and adrenal androgen excess in PCOS, this is a clinically relevant target.

Ones Endocrine Support blend: This proprietary blend is designed for hormonal axis regulation and includes ingredients that support adrenal and ovarian hormone balance — directly relevant for the HPA-HPO crosstalk that drives LH dysregulation in PCOS.

Magnesium Glycinate: Magnesium deficiency is highly prevalent in insulin-resistant states, and insulin resistance is both a cause and consequence of LH-driven androgen excess. Magnesium supplementation has been associated with improvements in insulin sensitivity and reductions in fasting glucose in populations with metabolic dysfunction (Mooren et al., Diabetologia 2011; PMID: 21184051), making it a relevant supporting nutrient in the PCOS hormonal picture.

Formulas through Ones come in 6 or 9-capsule daily plans, calibrated by the AI practitioner to your specific findings — not a generic women's hormone blend, but a formula built around what your labs and history actually show.

---

Key Takeaways

• LH is elevated in most women with PCOS, driven by faster GnRH pulse frequency at the hypothalamus — this is the upstream driver of androgen excess and anovulation.
• The LH:FSH ratio of ≥2:1 is clinically meaningful even though it is no longer required for Rotterdam diagnosis; a ratio above 2 correlates with more severe ovulatory dysfunction.
• Insulin resistance amplifies LH dysregulation by directly stimulating ovarian androgen production and suppressing SHBG — addressing glucose metabolism is often the highest-leverage intervention.
• Chronic stress has a real hormonal mechanism — adrenal androgen excess and cortisol dysregulation sustain LH imbalance and can trigger symptomatic flares.
• LH may appear falsely normal in women with higher BMI and significant insulin resistance, making SHBG and free androgen index more informative markers in this group.
• Tumors and structural causes must be excluded before attributing elevated androgens or LH solely to PCOS — rapid-onset symptoms or very high testosterone warrant specialist evaluation.

This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before making changes to your supplement regimen or medical treatment plan.